Home > > > Report Detail

Covid-19 Impact on Inflammatory Bowel Disease Therapeutics Market, Global Research Reports 2020-2021

Publisher Name :
Date: 15-May-2020
No. of pages: 98
Inquire Before Buying

This report covers market size and forecasts of Inflammatory Bowel Disease Therapeutics, including the following market information:

- Global Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Inflammatory Bowel Disease Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Inflammatory Bowel Disease Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Inflammatory Bowel Disease Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players

Major competitors identified in this market include Abbvie, Johnson & Johnson, GlaxoSmithKline, Merck, Novartis, etc.

Based on the Region:

- Asia-Pacific (China, Japan, South Korea, India and ASEAN)

- North America (US and Canada)

- Europe (Germany, France, UK and Italy)

- Rest of World (Latin America, Middle East & Africa)

Based on the Type:

- Anti-inflammatory Biologics

- Non-Steroidal Anti-inflammatory drugs (NSAIDs)

- Corticosteroids

Based on the Application:

- Hospital Use

- Home Use

Covid-19 Impact on Inflammatory Bowel Disease Therapeutics Market, Global Research Reports 2020-2021

Table of Contents
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Inflammatory Bowel Disease Therapeutics Industry
1.7 COVID-19 Impact: Inflammatory Bowel Disease Therapeutics Market Trends
2 Global Inflammatory Bowel Disease Therapeutics Quarterly Market Size Analysis
2.1 Inflammatory Bowel Disease Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Inflammatory Bowel Disease Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Inflammatory Bowel Disease Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Inflammatory Bowel Disease Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Inflammatory Bowel Disease Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Inflammatory Bowel Disease Therapeutics Market
3.4 Key Players Inflammatory Bowel Disease Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Inflammatory Bowel Disease Therapeutics Segments, By Type
4.1 Introduction
1.4.1 Anti-inflammatory Biologics
1.4.2 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.4.3 Corticosteroids
4.2 By Type, Global Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021
5 Impact of Covid-19 on Inflammatory Bowel Disease Therapeutics Segments, By Application
5.1 Overview
5.5.1 Hospital Use
5.5.2 Home Use
5.2 By Application, Global Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Inflammatory Bowel Disease Therapeutics Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Abbvie
7.1.1 Abbvie Business Overview
7.1.2 Abbvie Inflammatory Bowel Disease Therapeutics Quarterly Revenue, 2020
7.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Product Introduction
7.1.4 Abbvie Response to COVID-19 and Related Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Business Overview
7.2.2 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Quarterly Revenue, 2020
7.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product Introduction
7.2.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Business Overview
7.3.2 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Quarterly Revenue, 2020
7.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product Introduction
7.3.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.4 Merck
7.4.1 Merck Business Overview
7.4.2 Merck Inflammatory Bowel Disease Therapeutics Quarterly Revenue, 2020
7.4.3 Merck Inflammatory Bowel Disease Therapeutics Product Introduction
7.4.4 Merck Response to COVID-19 and Related Developments
7.5 Novartis
7.5.1 Novartis Business Overview
7.5.2 Novartis Inflammatory Bowel Disease Therapeutics Quarterly Revenue, 2020
7.5.3 Novartis Inflammatory Bowel Disease Therapeutics Product Introduction
7.5.4 Novartis Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Inflammatory Bowel Disease Therapeutics Assessment
Table 9. COVID-19 Impact: Inflammatory Bowel Disease Therapeutics Market Trends
Table 10. COVID-19 Impact Global Inflammatory Bowel Disease Therapeutics Market Size
Table 11. Global Inflammatory Bowel Disease Therapeutics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Inflammatory Bowel Disease Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Inflammatory Bowel Disease Therapeutics Market Growth Drivers
Table 14. Global Inflammatory Bowel Disease Therapeutics Market Restraints
Table 15. Global Inflammatory Bowel Disease Therapeutics Market Opportunities
Table 16. Global Inflammatory Bowel Disease Therapeutics Market Challenges
Table 17. By Players, Inflammatory Bowel Disease Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Inflammatory Bowel Disease Therapeutics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Inflammatory Bowel Disease Therapeutics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Inflammatory Bowel Disease Therapeutics Market
Table 21. Key Players Inflammatory Bowel Disease Therapeutics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Inflammatory Bowel Disease Therapeutics Market Size 2019-2021, (US$ Million)
Table 24. Global Inflammatory Bowel Disease Therapeutics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Inflammatory Bowel Disease Therapeutics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Inflammatory Bowel Disease Therapeutics Market Size, 2019-2021 (US$ Million)
Table 57. Abbvie Business Overview
Table 58. Abbvie Inflammatory Bowel Disease Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbvie Inflammatory Bowel Disease Therapeutics Product
Table 60. Abbvie Response to COVID-19 and Related Developments
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product
Table 64. Johnson & Johnson Response to COVID-19 and Related Developments
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product
Table 68. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 69. Merck Business Overview
Table 70. Merck Inflammatory Bowel Disease Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Merck Inflammatory Bowel Disease Therapeutics Product
Table 72. Merck Response to COVID-19 and Related Developments
Table 73. Novartis Business Overview
Table 74. Novartis Inflammatory Bowel Disease Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Novartis Inflammatory Bowel Disease Therapeutics Product
Table 76. Novartis Response to COVID-19 and Related Developments
List of Figures
Figure 1. Inflammatory Bowel Disease Therapeutics Product Picture
Figure 2. Inflammatory Bowel Disease Therapeutics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Inflammatory Bowel Disease Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Inflammatory Bowel Disease Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Inflammatory Bowel Disease Therapeutics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Inflammatory Bowel Disease Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Inflammatory Bowel Disease Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Inflammatory Bowel Disease Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size Market Share, 2019-2021
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs